0001209191-23-023674.txt : 20230406
0001209191-23-023674.hdr.sgml : 20230406
20230406203059
ACCESSION NUMBER: 0001209191-23-023674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230404
FILED AS OF DATE: 20230406
DATE AS OF CHANGE: 20230406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kintz Samuel
CENTRAL INDEX KEY: 0001967168
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 23807562
MAIL ADDRESS:
STREET 1: ENLIVEN THERAPEUTICS INC
STREET 2: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-04
0
0001672619
Enliven Therapeutics, Inc.
ELVN
0001967168
Kintz Samuel
C/O ENLIVEN THERAPEUTICS, INC.
6200 LOOKOUT ROAD
BOULDER
CO
80301
1
1
0
0
President and CEO
0
Stock Option (right to buy)
22.75
2023-04-04
4
A
0
452000
0.00
A
2033-04-04
Common Stock
452000
452000
D
1/4th of the shares subject to the option will vest on February 23, 2024 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date
/s/ Ben Hohl, by power of attorney
2023-04-06